Sunshine Biopharma (SBFM) Total Liabilities (2010 - 2026)
Sunshine Biopharma's (SBFM) quarterly Total Liabilities came in at $6.4 million in Q1 2026, down 1.09% YoY from $6.5 million in Q1 2025, and down 8.9% on a QoQ basis from $7.0 million in Q4 2025.
Sunshine Biopharma (SBFM) Total Liabilities (2010 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 16 years of Total Liabilities data on file, last reported at $6.4 million in Q1 2026.
- Quarterly Total Liabilities fell 1.09% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (down 1.09% YoY) and the FY2025 annual result came in at $7.0 million, changed 0.27% from the prior year.
- Total Liabilities slipped to $6.4 million in Q1 2026, from $7.0 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $7.6 million in Q4 2022 to a low of $95234.0 in Q1 2022.
- A 5-year average of $5.4 million and a median of $6.3 million in 2025 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities slumped 96.76% — and 2023, when it surged 7840.3%.
- Tracing SBFM's Total Liabilities over 5 years: stood at $7.6 million in 2022, then decreased by 19.39% to $6.1 million in 2023, then gained by 14.99% to $7.1 million in 2024, then retreated by 0.27% to $7.0 million in 2025, then retreated by 8.9% to $6.4 million in 2026.
- The last three Total Liabilities figures came in at $6.4 million (Q1 2026), $7.0 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | 6.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.09 Mn |
| Mar 31, 2026 | 6.41 Mn |
| Dec 31, 2025 | 7.04 Mn |
| Sep 30, 2025 | 7.29 Mn |
| Jun 30, 2025 | 6.28 Mn |
| Mar 31, 2025 | 6.48 Mn |
| Dec 31, 2024 | 7.06 Mn |
| Sep 30, 2024 | 5.02 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Mar 31, 2024 | 7.08 Mn |
| Dec 31, 2023 | 6.14 Mn |
| Sep 30, 2023 | 5.69 Mn |
| Jun 30, 2023 | 5.30 Mn |
| Mar 31, 2023 | 7.56 Mn |
| Dec 31, 2022 | 7.62 Mn |
| Sep 30, 2022 | 480,209.00 |
| Jun 30, 2022 | 104,684.00 |
| Mar 31, 2022 | 95,234.00 |
| Dec 31, 2021 | 1.99 Mn |
| Sep 30, 2021 | 3.68 Mn |